The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism

Autor: Jiménez-Fonseca P, Carmona-Bayonas A, Font C, Plasencia-Martínez J, Calvo-Temprano D, Otero R, Beato C, Biosca M, Sánchez M, Benegas M, Varona D, Faez L, Antonio M, de la Haba I, Madridano O, Solis MP, Ramchandani A, Castañón E, PABLO MARCHENA YGLESIAS, Martín M, de la Peña FA, Vicente V, EPIPHANY study investigators and the Asociación de Investigación de la Enfermeda

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu

AIM: To assess the prevalence and prognostic significance of additional intrathoracic findings (AIFs) in patients with cancer and pulmonary embolism (PE). AIFs were considered alterations other than the characteristic ones intrinsic to PE or changes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a138933d4c564ea62268de4b84b335f9
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12670

Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study.

Autor: Font C; Medical Oncology Dept, IDIBAPS/Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clinic de Barcelona, Barcelona, Spain CFONT@clinic.ub.es., Carmona-Bayonas A; Medical Oncology and Hematology Dept, Hospital Universitario Morales Meseguer, Murcia, Spain., Beato C; Medical Oncology Dept, Hospital Nisa-Aljarafe, Sevilla, Spain., Reig Ò; Medical Oncology Dept, IDIBAPS/Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clinic de Barcelona, Barcelona, Spain., Sáez A; Statistical Dept, Axioma Comunicaciones, Sevilla, Spain., Jiménez-Fonseca P; Medical Oncology Dept, Hospital Universitario Central de Asturias, Oviedo, Spain., Plasencia JM; Radiology Dept, Hospital Universitario Morales Meseguer, Murcia, Spain., Calvo-Temprano D; Radiology Dept, Hospital Universitario Central de Asturias, Oviedo, Spain., Sanchez M; Radiodiagnostic Dept, Hospital Clinic de Barcelona, Barcelona, Spain., Benegas M; Radiodiagnostic Dept, Hospital Clinic de Barcelona, Barcelona, Spain., Biosca M; Medical Oncology Dept, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Varona D; Radiology Dept, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Vicente MA; Medical Oncology and Hematology Dept, Hospital Universitario Morales Meseguer, Murcia, Spain., Faez L; Medical Oncology Dept, Hospital Universitario Central de Asturias, Oviedo, Spain., Solís MD; Medical Oncology Dept, Hospital Universitario Central de Asturias, Oviedo, Spain., de la Haba I; Medical Oncology Dept, Hospital Duran i Reynals, Institut Catalàd'Oncologia, Hospitalet de Llobregat, Barcelona, Spain., Antonio M; Medical Oncology Dept, Hospital Duran i Reynals, Institut Catalàd'Oncologia, Hospitalet de Llobregat, Barcelona, Spain., Madridano O; Internal Medicine Dept, Hospital Infanta Sofía. San Sebastian de los Reves, Madrid, Spain., Castañon E; Medical Oncology Dept, Clinica Universidad de Navarra, Pamplona, Spain., Martinez MJ; Medical Oncology Dept, Hospital Santa Lucía, Cartagena, Murcia, Spain., Marchena P; Internal Medicine Dept, Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain., Ramchandani A; Medical Oncology Dept, Hospital Insular de Gran Canaria, Las Palmas, Spain., Dominguez A; Radiology Dept, Hospital Nisa-Aljarafe, Sevilla, Spain., Puerta A; Radiology Dept, Hospital Reina Sofía, Murcia, Spain., Martinez de la Haza D; Radiology Dept, Hospital Duran i Reynals, InstitutCatalàd'Oncologia, Hospitalet de Llobregat, Barcelona, Spain., Pueyo J; Radiology Dept, Clinica Universidad de Navarra, Pamplona, Spain., Hernandez S; Radiology Dept, Hospital Infanta Sofía. San Sebastian de los Reves, Madrid, Spain., Fernandez-Plaza A; Radiology Dept, Hospital Santa Lucía, Cartagena, Murcia, Spain., Martinez-Encarnacion L; Radiology Dept, Hospital Santa Lucía, Cartagena, Murcia, Spain., Martin M; Internal Medicine Dept, Hospital Infanta Sofía. San Sebastian de los Reves, Madrid, Spain., Marin G; Medical Oncology Dept, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Ayala F; Medical Oncology and Hematology Dept, Hospital Universitario Morales Meseguer, Murcia, Spain., Vicente V; Medical Oncology and Hematology Dept, Hospital Universitario Morales Meseguer, Murcia, Spain., Otero R; Dept of Pneumology, Hospital Universitario Virgen del Rocío (HUVR-IBiS). CIBERES, Sevilla, Spain.

Publikováno v: The European respiratory journal [Eur Respir J] 2017 Jan 04; Vol. 49 (1). Date of Electronic Publication: 2017 Jan 04 (Print Publication: 2017).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China.

Autor: Wang, Yanfei¹ (AUTHOR), Liu, Zhongfen² (AUTHOR), Li, Qiuyu³ (AUTHOR), Xia, Lina² (AUTHOR), Wang, Yunyi¹ (AUTHOR), Jiang, Danfeng¹ (AUTHOR), Chen, Xiaoyan¹ (AUTHOR), Zheng, Yanqun¹ (AUTHOR), Liu, Wei^1,2 (AUTHOR), Wang, Dan⁴ (AUTHOR) hsm20072007@163.com, Xue, Dong^4,5 (AUTHOR) xuedong123321@hotmail.com

Publikováno v: Thrombosis Journal. 6/6/2023, Vol. 21 Issue 1, p1-12. 12p.

Transketolase Catalyzed Synthesis of N‐Aryl Hydroxamic Acids.

Autor: Fúster Fernández, Inés¹ (AUTHOR), Hecquet, Laurence² (AUTHOR), Fessner, Wolf‐Dieter¹ (AUTHOR) fessner@tu-darmstadt.de

Publikováno v: Advanced Synthesis & Catalysis. 2/1/2022, Vol. 364 Issue 3, p612-621. 10p.